BindingDB logo
myBDB logout

39 similar compounds to monomer 144758

Compile data set for download or QSAR
Wt: 1602.9
BDBM144773
Wt: 1440.7
BDBM144764
Wt: 1454.7
BDBM144765
Wt: 1470.7
BDBM144766
Wt: 1439.8
BDBM144767
Wt: 1603.9
BDBM144740
Wt: 1739.2
BDBM144771
Wt: 1620.9
BDBM144741
Wt: 1457.8
BDBM144742
Wt: 1475.7
BDBM144743
Wt: 1475.7
BDBM144744
Wt: 1618.9
BDBM144776
Wt: 1457.8
BDBM144745
Wt: 1457.8
BDBM144746
Wt: 1471.7
BDBM144777
Displayed 1 to 15 (of 39 total )  |  Next  |  Last  >>

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 55 hits for monomerid = 144773,144764,144765,144766,144767,144740,144771,144741,144742,144743,144744,144776,144745,144746,144777   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144766
PNG
(US8952128, 25)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H99N17O11S/c1-45(95)68-76(105)92-61(36-47-23-25-52(96)26-24-47)69(98)82-30-11-9-20-58(86-66(97)44-106-43-49-34-55-54-17-12-21-57-67(54)51(41-85-57)39-65(55)94(2)42-49)70(99)87-60(22-13-31-83-77(79)80)71(100)89-62(35-46-14-4-3-5-15-46)73(102)90-63(37-48-27-32-81-33-28-48)74(103)91-64(38-50-40-84-56-18-7-6-16-53(50)56)75(104)88-59(72(101)93-68)19-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,40-41,45,49,55,58-65,68,84-85,95-96H,8-11,13,19-20,22,29-31,34-39,42-44,78H2,1-2H3,(H,82,98)(H,86,97)(H,87,99)(H,88,104)(H,89,100)(H,90,102)(H,91,103)(H,92,105)(H,93,101)(H4,79,80,83)/t45-,49-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.0500 -14.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144765
PNG
(US8952128, 24)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.0800 -13.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144764
PNG
(US8952128, 23)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H101N17O9S/c1-47(95)68-76(103)92-62(38-48-17-5-3-6-18-48)69(96)83-31-14-12-24-59(82-35-36-104-46-51-37-56-55-22-15-26-58-67(55)53(44-86-58)42-66(56)94(2)45-51)70(97)87-61(27-16-32-84-77(79)80)71(98)89-63(39-49-19-7-4-8-20-49)73(100)90-64(40-50-28-33-81-34-29-50)74(101)91-65(41-52-43-85-57-23-10-9-21-54(52)57)75(102)88-60(72(99)93-68)25-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,43-44,47,51,56,59-66,68,82,85-86,95H,11-14,16,24-25,27,30-32,35-42,45-46,78H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,79,80,84)/t47-,51-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.0900 -13.7n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144740
PNG
(US8952128, 4)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O11S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-116-50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.120 -13.5n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144771
PNG
(US8952128, 29)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)N(CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C95H123N19O9S2/c1-58(115)86-94(123)110-77(45-59-19-6-4-7-20-59)87(116)100-35-15-13-31-81(114(39-41-124-56-62-43-70-68-24-16-28-73-84(68)65(52-103-73)49-82(70)112(2)54-62)40-42-125-57-63-44-71-69-25-17-29-74-85(69)66(53-104-74)50-83(71)113(3)55-63)93(122)106-76(30-18-36-101-95(97)98)88(117)107-78(46-60-21-8-5-9-22-60)90(119)108-79(47-61-32-37-99-38-33-61)91(120)109-80(48-64-51-102-72-26-11-10-23-67(64)72)92(121)105-75(89(118)111-86)27-12-14-34-96/h4-11,16-17,19-26,28-29,32-33,37-38,51-53,58,62-63,70-71,75-83,86,102-104,115H,12-15,18,27,30-31,34-36,39-50,54-57,96H2,1-3H3,(H,100,116)(H,105,121)(H,106,122)(H,107,117)(H,108,119)(H,109,120)(H,110,123)(H,111,118)(H4,97,98,101)/t58-,62-,63-,70-,71-,75+,76+,77+,78+,79+,80-,81-,82-,83-,86+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.140 -13.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144745
PNG
(US8952128, 6C)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2cccc(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-22-15-23-54(79)36-50)70(97)84-32-14-12-27-60(83-34-35-105-46-51-37-57-56-25-16-29-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(30-17-33-85-78(81)82)72(99)90-64(38-48-18-5-3-6-19-48)74(101)91-65(39-49-20-7-4-8-21-49)75(102)92-66(41-52-43-86-58-26-10-9-24-55(52)58)76(103)89-61(73(100)94-69)28-11-13-31-80/h3-10,15-16,18-26,29,36,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,17,27-28,30-35,37-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.150 -13.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144776
PNG
(US8952128, 33)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O12S/c1-52(105)78-86(116)102-71(43-56-30-34-62(107)35-31-56)79(109)91-37-14-12-24-68(95-48-60(39-55-28-32-61(106)33-29-55)96-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-94-67)45-75(65)104(2)49-57)80(110)97-70(27-16-38-92-87(89)90)81(111)99-72(41-53-17-5-3-6-18-53)83(113)100-73(42-54-19-7-4-8-20-54)84(114)101-74(44-58-46-93-66-23-10-9-21-63(58)66)85(115)98-69(82(112)103-78)25-11-13-36-88/h3-10,15,17-23,26,28-35,46-47,52,57,60,65,68-75,78,93-95,105-107H,11-14,16,24-25,27,36-45,48-51,88H2,1-2H3,(H,91,109)(H,96,108)(H,97,110)(H,98,115)(H,99,111)(H,100,113)(H,101,114)(H,102,116)(H,103,112)(H4,89,90,92)/t52-,57-,60+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.240 -13.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144744
PNG
(US8952128, 6B)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2cc(F)cc(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H100F2N16O9S/c1-46(97)69-77(105)94-63(38-49-33-53(79)41-54(80)34-49)70(98)85-29-14-12-24-60(84-31-32-106-45-50-35-57-56-22-15-26-59-68(56)52(43-88-59)40-67(57)96(2)44-50)71(99)89-62(27-16-30-86-78(82)83)72(100)91-64(36-47-17-5-3-6-18-47)74(102)92-65(37-48-19-7-4-8-20-48)75(103)93-66(39-51-42-87-58-23-10-9-21-55(51)58)76(104)90-61(73(101)95-69)25-11-13-28-81/h3-10,15,17-23,26,33-34,41-43,46,50,57,60-67,69,84,87-88,97H,11-14,16,24-25,27-32,35-40,44-45,81H2,1-2H3,(H,85,98)(H,89,99)(H,90,104)(H,91,100)(H,92,102)(H,93,103)(H,94,105)(H,95,101)(H4,82,83,86)/t46-,50-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.25 -13.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144773
PNG
(US8952128, 30 | US8952128, 32)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O11S/c1-53(105)78-86(115)102-71(42-54-20-6-3-7-21-54)79(108)91-38-17-15-29-68(95-49-61(40-57-33-35-62(106)36-34-57)96-76(107)52-116-51-58-41-65-64-27-18-31-67-77(64)60(48-94-67)46-75(65)104(2)50-58)80(109)97-70(32-19-39-92-87(89)90)81(110)99-72(43-55-22-8-4-9-23-55)83(112)100-73(44-56-24-10-5-11-25-56)84(113)101-74(45-59-47-93-66-28-13-12-26-63(59)66)85(114)98-69(82(111)103-78)30-14-16-37-88/h3-13,18,20-28,31,33-36,47-48,53,58,61,65,68-75,78,93-95,105-106H,14-17,19,29-30,32,37-46,49-52,88H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,89,90,92)/t53-,58-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.280 -13.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144742
PNG
(US8952128, 6)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-105-46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.300 -13.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144741
PNG
(US8952128, 5)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H110FN17O11S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.340 -12.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144743
PNG
(US8952128, 6A)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)c(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H100F2N16O9S/c1-46(97)69-77(105)94-63(39-49-28-29-56(79)57(80)36-49)70(98)85-31-14-12-24-60(84-33-34-106-45-50-35-55-54-22-15-26-59-68(54)52(43-88-59)41-67(55)96(2)44-50)71(99)89-62(27-16-32-86-78(82)83)72(100)91-64(37-47-17-5-3-6-18-47)74(102)92-65(38-48-19-7-4-8-20-48)75(103)93-66(40-51-42-87-58-23-10-9-21-53(51)58)76(104)90-61(73(101)95-69)25-11-13-30-81/h3-10,15,17-23,26,28-29,36,42-43,46,50,55,60-67,69,84,87-88,97H,11-14,16,24-25,27,30-35,37-41,44-45,81H2,1-2H3,(H,85,98)(H,89,99)(H,90,104)(H,91,100)(H,92,102)(H,93,103)(H,94,105)(H,95,101)(H4,82,83,86)/t46-,50-,55-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.350 -12.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144773
PNG
(US8952128, 30 | US8952128, 32)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O11S/c1-53(105)78-86(115)102-71(42-54-20-6-3-7-21-54)79(108)91-38-17-15-29-68(95-49-61(40-57-33-35-62(106)36-34-57)96-76(107)52-116-51-58-41-65-64-27-18-31-67-77(64)60(48-94-67)46-75(65)104(2)50-58)80(109)97-70(32-19-39-92-87(89)90)81(110)99-72(43-55-22-8-4-9-23-55)83(112)100-73(44-56-24-10-5-11-25-56)84(113)101-74(45-59-47-93-66-28-13-12-26-63(59)66)85(114)98-69(82(111)103-78)30-14-16-37-88/h3-13,18,20-28,31,33-36,47-48,53,58,61,65,68-75,78,93-95,105-106H,14-17,19,29-30,32,37-46,49-52,88H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,89,90,92)/t53-,58-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.400 -12.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144742
PNG
(US8952128, 6)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-105-46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.520 -12.7n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144746
PNG
(US8952128, 6D)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2F)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-65(40-51-23-9-11-26-57(51)79)70(97)84-33-16-14-28-60(83-35-36-105-46-50-37-56-55-25-17-30-59-68(55)53(44-87-59)42-67(56)95(2)45-50)71(98)88-62(31-18-34-85-78(81)82)72(99)90-63(38-48-19-5-3-6-20-48)74(101)91-64(39-49-21-7-4-8-22-49)75(102)92-66(41-52-43-86-58-27-12-10-24-54(52)58)76(103)89-61(73(100)94-69)29-13-15-32-80/h3-12,17,19-27,30,43-44,47,50,56,60-67,69,83,86-87,96H,13-16,18,28-29,31-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,50-,56-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.540 -12.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144776
PNG
(US8952128, 33)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O12S/c1-52(105)78-86(116)102-71(43-56-30-34-62(107)35-31-56)79(109)91-37-14-12-24-68(95-48-60(39-55-28-32-61(106)33-29-55)96-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-94-67)45-75(65)104(2)49-57)80(110)97-70(27-16-38-92-87(89)90)81(111)99-72(41-53-17-5-3-6-18-53)83(113)100-73(42-54-19-7-4-8-20-54)84(114)101-74(44-58-46-93-66-23-10-9-21-63(58)66)85(115)98-69(82(112)103-78)25-11-13-36-88/h3-10,15,17-23,26,28-35,46-47,52,57,60,65,68-75,78,93-95,105-107H,11-14,16,24-25,27,36-45,48-51,88H2,1-2H3,(H,91,109)(H,96,108)(H,97,110)(H,98,115)(H,99,111)(H,100,113)(H,101,114)(H,102,116)(H,103,112)(H4,89,90,92)/t52-,57-,60+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.820 -12.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144740
PNG
(US8952128, 4)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O11S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-116-50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.920 -12.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144766
PNG
(US8952128, 25)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H99N17O11S/c1-45(95)68-76(105)92-61(36-47-23-25-52(96)26-24-47)69(98)82-30-11-9-20-58(86-66(97)44-106-43-49-34-55-54-17-12-21-57-67(54)51(41-85-57)39-65(55)94(2)42-49)70(99)87-60(22-13-31-83-77(79)80)71(100)89-62(35-46-14-4-3-5-15-46)73(102)90-63(37-48-27-32-81-33-28-48)74(103)91-64(38-50-40-84-56-18-7-6-16-53(50)56)75(104)88-59(72(101)93-68)19-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,40-41,45,49,55,58-65,68,84-85,95-96H,8-11,13,19-20,22,29-31,34-39,42-44,78H2,1-2H3,(H,82,98)(H,86,97)(H,87,99)(H,88,104)(H,89,100)(H,90,102)(H,91,103)(H,92,105)(H,93,101)(H4,79,80,83)/t45-,49-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.950 -12.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM144741
PNG
(US8952128, 5)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H110FN17O11S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
1.5 -12.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144773
PNG
(US8952128, 30 | US8952128, 32)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O11S/c1-53(105)78-86(115)102-71(42-54-20-6-3-7-21-54)79(108)91-38-17-15-29-68(95-49-61(40-57-33-35-62(106)36-34-57)96-76(107)52-116-51-58-41-65-64-27-18-31-67-77(64)60(48-94-67)46-75(65)104(2)50-58)80(109)97-70(32-19-39-92-87(89)90)81(110)99-72(43-55-22-8-4-9-23-55)83(112)100-73(44-56-24-10-5-11-25-56)84(113)101-74(45-59-47-93-66-28-13-12-26-63(59)66)85(114)98-69(82(111)103-78)30-14-16-37-88/h3-13,18,20-28,31,33-36,47-48,53,58,61,65,68-75,78,93-95,105-106H,14-17,19,29-30,32,37-46,49-52,88H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,89,90,92)/t53-,58-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
1.58 -12.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144741
PNG
(US8952128, 5)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H110FN17O11S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
1.65 -12.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM144742
PNG
(US8952128, 6)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-105-46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
2.10 -11.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144767
PNG
(US8952128, 26)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H102N16O9S/c1-48(95)69-77(103)92-63(39-49-20-6-3-7-21-49)70(96)83-34-17-15-29-60(82-36-37-104-47-52-38-57-56-27-18-31-59-68(56)54(45-86-59)43-67(57)94(2)46-52)71(97)87-62(32-19-35-84-78(80)81)72(98)89-64(40-50-22-8-4-9-23-50)74(100)90-65(41-51-24-10-5-11-25-51)75(101)91-66(42-53-44-85-58-28-13-12-26-55(53)58)76(102)88-61(73(99)93-69)30-14-16-33-79/h3-13,18,20-28,31,44-45,48,52,57,60-67,69,82,85-86,95H,14-17,19,29-30,32-43,46-47,79H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,80,81,84)/t48-,52-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
2.23 -11.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144771
PNG
(US8952128, 29)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)N(CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C95H123N19O9S2/c1-58(115)86-94(123)110-77(45-59-19-6-4-7-20-59)87(116)100-35-15-13-31-81(114(39-41-124-56-62-43-70-68-24-16-28-73-84(68)65(52-103-73)49-82(70)112(2)54-62)40-42-125-57-63-44-71-69-25-17-29-74-85(69)66(53-104-74)50-83(71)113(3)55-63)93(122)106-76(30-18-36-101-95(97)98)88(117)107-78(46-60-21-8-5-9-22-60)90(119)108-79(47-61-32-37-99-38-33-61)91(120)109-80(48-64-51-102-72-26-11-10-23-67(64)72)92(121)105-75(89(118)111-86)27-12-14-34-96/h4-11,16-17,19-26,28-29,32-33,37-38,51-53,58,62-63,70-71,75-83,86,102-104,115H,12-15,18,27,30-31,34-36,39-50,54-57,96H2,1-3H3,(H,100,116)(H,105,121)(H,106,122)(H,107,117)(H,108,119)(H,109,120)(H,110,123)(H,111,118)(H4,97,98,101)/t58-,62-,63-,70-,71-,75+,76+,77+,78+,79+,80-,81-,82-,83-,86+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
2.37 -11.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144765
PNG
(US8952128, 24)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
2.39 -11.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144777
PNG
(US8952128, 34)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H99FN16O10S/c1-46(96)69-77(105)93-62(38-49-28-30-53(79)31-29-49)70(98)83-33-14-12-25-59(87-67(97)45-106-44-50-35-56-55-22-15-26-58-68(55)52(42-86-58)40-66(56)95(2)43-50)71(99)88-61(27-16-34-84-78(81)82)72(100)90-63(36-47-17-5-3-6-18-47)74(102)91-64(37-48-19-7-4-8-20-48)75(103)92-65(39-51-41-85-57-23-10-9-21-54(51)57)76(104)89-60(73(101)94-69)24-11-13-32-80/h3-10,15,17-23,26,28-31,41-42,46,50,56,59-66,69,85-86,96H,11-14,16,24-25,27,32-40,43-45,80H2,1-2H3,(H,83,98)(H,87,97)(H,88,99)(H,89,104)(H,90,100)(H,91,102)(H,92,103)(H,93,105)(H,94,101)(H4,81,82,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
4.55 -11.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144773
PNG
(US8952128, 30 | US8952128, 32)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O11S/c1-53(105)78-86(115)102-71(42-54-20-6-3-7-21-54)79(108)91-38-17-15-29-68(95-49-61(40-57-33-35-62(106)36-34-57)96-76(107)52-116-51-58-41-65-64-27-18-31-67-77(64)60(48-94-67)46-75(65)104(2)50-58)80(109)97-70(32-19-39-92-87(89)90)81(110)99-72(43-55-22-8-4-9-23-55)83(112)100-73(44-56-24-10-5-11-25-56)84(113)101-74(45-59-47-93-66-28-13-12-26-63(59)66)85(114)98-69(82(111)103-78)30-14-16-37-88/h3-13,18,20-28,31,33-36,47-48,53,58,61,65,68-75,78,93-95,105-106H,14-17,19,29-30,32,37-46,49-52,88H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,89,90,92)/t53-,58-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
5.30 -11.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144741
PNG
(US8952128, 5)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H110FN17O11S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
9 -11.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144776
PNG
(US8952128, 33)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O12S/c1-52(105)78-86(116)102-71(43-56-30-34-62(107)35-31-56)79(109)91-37-14-12-24-68(95-48-60(39-55-28-32-61(106)33-29-55)96-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-94-67)45-75(65)104(2)49-57)80(110)97-70(27-16-38-92-87(89)90)81(111)99-72(41-53-17-5-3-6-18-53)83(113)100-73(42-54-19-7-4-8-20-54)84(114)101-74(44-58-46-93-66-23-10-9-21-63(58)66)85(115)98-69(82(112)103-78)25-11-13-36-88/h3-10,15,17-23,26,28-35,46-47,52,57,60,65,68-75,78,93-95,105-107H,11-14,16,24-25,27,36-45,48-51,88H2,1-2H3,(H,91,109)(H,96,108)(H,97,110)(H,98,115)(H,99,111)(H,100,113)(H,101,114)(H,102,116)(H,103,112)(H4,89,90,92)/t52-,57-,60+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
10.4 -10.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM144740
PNG
(US8952128, 4)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O11S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-116-50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
10.6 -10.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144776
PNG
(US8952128, 33)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O12S/c1-52(105)78-86(116)102-71(43-56-30-34-62(107)35-31-56)79(109)91-37-14-12-24-68(95-48-60(39-55-28-32-61(106)33-29-55)96-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-94-67)45-75(65)104(2)49-57)80(110)97-70(27-16-38-92-87(89)90)81(111)99-72(41-53-17-5-3-6-18-53)83(113)100-73(42-54-19-7-4-8-20-54)84(114)101-74(44-58-46-93-66-23-10-9-21-63(58)66)85(115)98-69(82(112)103-78)25-11-13-36-88/h3-10,15,17-23,26,28-35,46-47,52,57,60,65,68-75,78,93-95,105-107H,11-14,16,24-25,27,36-45,48-51,88H2,1-2H3,(H,91,109)(H,96,108)(H,97,110)(H,98,115)(H,99,111)(H,100,113)(H,101,114)(H,102,116)(H,103,112)(H4,89,90,92)/t52-,57-,60+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
15n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144743
PNG
(US8952128, 6A)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)c(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H100F2N16O9S/c1-46(97)69-77(105)94-63(39-49-28-29-56(79)57(80)36-49)70(98)85-31-14-12-24-60(84-33-34-106-45-50-35-55-54-22-15-26-59-68(54)52(43-88-59)41-67(55)96(2)44-50)71(99)89-62(27-16-32-86-78(82)83)72(100)91-64(37-47-17-5-3-6-18-47)74(102)92-65(38-48-19-7-4-8-20-48)75(103)93-66(40-51-42-87-58-23-10-9-21-53(51)58)76(104)90-61(73(101)95-69)25-11-13-30-81/h3-10,15,17-23,26,28-29,36,42-43,46,50,55,60-67,69,84,87-88,97H,11-14,16,24-25,27,30-35,37-41,44-45,81H2,1-2H3,(H,85,98)(H,89,99)(H,90,104)(H,91,100)(H,92,102)(H,93,103)(H,94,105)(H,95,101)(H4,82,83,86)/t46-,50-,55-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
16.9n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144773
PNG
(US8952128, 30 | US8952128, 32)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O11S/c1-53(105)78-86(115)102-71(42-54-20-6-3-7-21-54)79(108)91-38-17-15-29-68(95-49-61(40-57-33-35-62(106)36-34-57)96-76(107)52-116-51-58-41-65-64-27-18-31-67-77(64)60(48-94-67)46-75(65)104(2)50-58)80(109)97-70(32-19-39-92-87(89)90)81(110)99-72(43-55-22-8-4-9-23-55)83(112)100-73(44-56-24-10-5-11-25-56)84(113)101-74(45-59-47-93-66-28-13-12-26-63(59)66)85(114)98-69(82(111)103-78)30-14-16-37-88/h3-13,18,20-28,31,33-36,47-48,53,58,61,65,68-75,78,93-95,105-106H,14-17,19,29-30,32,37-46,49-52,88H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,89,90,92)/t53-,58-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
24.2n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM144741
PNG
(US8952128, 5)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H110FN17O11S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
25.2 -10.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144744
PNG
(US8952128, 6B)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2cc(F)cc(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H100F2N16O9S/c1-46(97)69-77(105)94-63(38-49-33-53(79)41-54(80)34-49)70(98)85-29-14-12-24-60(84-31-32-106-45-50-35-57-56-22-15-26-59-68(56)52(43-88-59)40-67(57)96(2)44-50)71(99)89-62(27-16-30-86-78(82)83)72(100)91-64(36-47-17-5-3-6-18-47)74(102)92-65(37-48-19-7-4-8-20-48)75(103)93-66(39-51-42-87-58-23-10-9-21-55(51)58)76(104)90-61(73(101)95-69)25-11-13-28-81/h3-10,15,17-23,26,33-34,41-43,46,50,57,60-67,69,84,87-88,97H,11-14,16,24-25,27-32,35-40,44-45,81H2,1-2H3,(H,85,98)(H,89,99)(H,90,104)(H,91,100)(H,92,102)(H,93,103)(H,94,105)(H,95,101)(H4,82,83,86)/t46-,50-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
25.4n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144771
PNG
(US8952128, 29)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)N(CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C95H123N19O9S2/c1-58(115)86-94(123)110-77(45-59-19-6-4-7-20-59)87(116)100-35-15-13-31-81(114(39-41-124-56-62-43-70-68-24-16-28-73-84(68)65(52-103-73)49-82(70)112(2)54-62)40-42-125-57-63-44-71-69-25-17-29-74-85(69)66(53-104-74)50-83(71)113(3)55-63)93(122)106-76(30-18-36-101-95(97)98)88(117)107-78(46-60-21-8-5-9-22-60)90(119)108-79(47-61-32-37-99-38-33-61)91(120)109-80(48-64-51-102-72-26-11-10-23-67(64)72)92(121)105-75(89(118)111-86)27-12-14-34-96/h4-11,16-17,19-26,28-29,32-33,37-38,51-53,58,62-63,70-71,75-83,86,102-104,115H,12-15,18,27,30-31,34-36,39-50,54-57,96H2,1-3H3,(H,100,116)(H,105,121)(H,106,122)(H,107,117)(H,108,119)(H,109,120)(H,110,123)(H,111,118)(H4,97,98,101)/t58-,62-,63-,70-,71-,75+,76+,77+,78+,79+,80-,81-,82-,83-,86+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
26.7 -10.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144741
PNG
(US8952128, 5)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H110FN17O11S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
28.5n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144745
PNG
(US8952128, 6C)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2cccc(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-22-15-23-54(79)36-50)70(97)84-32-14-12-27-60(83-34-35-105-46-51-37-57-56-25-16-29-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(30-17-33-85-78(81)82)72(99)90-64(38-48-18-5-3-6-19-48)74(101)91-65(39-49-20-7-4-8-21-49)75(102)92-66(41-52-43-86-58-26-10-9-24-55(52)58)76(103)89-61(73(100)94-69)28-11-13-31-80/h3-10,15-16,18-26,29,36,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,17,27-28,30-35,37-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
30.3n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144746
PNG
(US8952128, 6D)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2F)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-65(40-51-23-9-11-26-57(51)79)70(97)84-33-16-14-28-60(83-35-36-105-46-50-37-56-55-25-17-30-59-68(55)53(44-87-59)42-67(56)95(2)45-50)71(98)88-62(31-18-34-85-78(81)82)72(99)90-63(38-48-19-5-3-6-20-48)74(101)91-64(39-49-21-7-4-8-22-49)75(102)92-66(41-52-43-86-58-27-12-10-24-54(52)58)76(103)89-61(73(100)94-69)29-13-15-32-80/h3-12,17,19-27,30,43-44,47,50,56,60-67,69,83,86-87,96H,13-16,18,28-29,31-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,50-,56-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
31.8n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144742
PNG
(US8952128, 6)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-105-46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
32.2 -10.2n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144740
PNG
(US8952128, 4)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O11S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-116-50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
38.1 -10.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144766
PNG
(US8952128, 25)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H99N17O11S/c1-45(95)68-76(105)92-61(36-47-23-25-52(96)26-24-47)69(98)82-30-11-9-20-58(86-66(97)44-106-43-49-34-55-54-17-12-21-57-67(54)51(41-85-57)39-65(55)94(2)42-49)70(99)87-60(22-13-31-83-77(79)80)71(100)89-62(35-46-14-4-3-5-15-46)73(102)90-63(37-48-27-32-81-33-28-48)74(103)91-64(38-50-40-84-56-18-7-6-16-53(50)56)75(104)88-59(72(101)93-68)19-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,40-41,45,49,55,58-65,68,84-85,95-96H,8-11,13,19-20,22,29-31,34-39,42-44,78H2,1-2H3,(H,82,98)(H,86,97)(H,87,99)(H,88,104)(H,89,100)(H,90,102)(H,91,103)(H,92,105)(H,93,101)(H4,79,80,83)/t45-,49-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
41.9 -10.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144773
PNG
(US8952128, 30 | US8952128, 32)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C87H111N17O11S/c1-53(105)78-86(115)102-71(42-54-20-6-3-7-21-54)79(108)91-38-17-15-29-68(95-49-61(40-57-33-35-62(106)36-34-57)96-76(107)52-116-51-58-41-65-64-27-18-31-67-77(64)60(48-94-67)46-75(65)104(2)50-58)80(109)97-70(32-19-39-92-87(89)90)81(110)99-72(43-55-22-8-4-9-23-55)83(112)100-73(44-56-24-10-5-11-25-56)84(113)101-74(45-59-47-93-66-28-13-12-26-63(59)66)85(114)98-69(82(111)103-78)30-14-16-37-88/h3-13,18,20-28,31,33-36,47-48,53,58,61,65,68-75,78,93-95,105-106H,14-17,19,29-30,32,37-46,49-52,88H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,89,90,92)/t53-,58-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
44n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144765
PNG
(US8952128, 24)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
47.7 -9.98n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144767
PNG
(US8952128, 26)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H102N16O9S/c1-48(95)69-77(103)92-63(39-49-20-6-3-7-21-49)70(96)83-34-17-15-29-60(82-36-37-104-47-52-38-57-56-27-18-31-59-68(56)54(45-86-59)43-67(57)94(2)46-52)71(97)87-62(32-19-35-84-78(80)81)72(98)89-64(40-50-22-8-4-9-23-50)74(100)90-65(41-51-24-10-5-11-25-51)75(101)91-66(42-53-44-85-58-28-13-12-26-55(53)58)76(102)88-61(73(99)93-69)30-14-16-33-79/h3-13,18,20-28,31,44-45,48,52,57,60-67,69,82,85-86,95H,14-17,19,29-30,32-43,46-47,79H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,80,81,84)/t48-,52-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
59 -9.86n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM144742
PNG
(US8952128, 6)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-105-46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
61.9 -9.83n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM144740
PNG
(US8952128, 4)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O11S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-116-50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+/m1/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
93.5 -9.58n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144742
PNG
(US8952128, 6)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-105-46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
101n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144771
PNG
(US8952128, 29)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)N(CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C95H123N19O9S2/c1-58(115)86-94(123)110-77(45-59-19-6-4-7-20-59)87(116)100-35-15-13-31-81(114(39-41-124-56-62-43-70-68-24-16-28-73-84(68)65(52-103-73)49-82(70)112(2)54-62)40-42-125-57-63-44-71-69-25-17-29-74-85(69)66(53-104-74)50-83(71)113(3)55-63)93(122)106-76(30-18-36-101-95(97)98)88(117)107-78(46-60-21-8-5-9-22-60)90(119)108-79(47-61-32-37-99-38-33-61)91(120)109-80(48-64-51-102-72-26-11-10-23-67(64)72)92(121)105-75(89(118)111-86)27-12-14-34-96/h4-11,16-17,19-26,28-29,32-33,37-38,51-53,58,62-63,70-71,75-83,86,102-104,115H,12-15,18,27,30-31,34-36,39-50,54-57,96H2,1-3H3,(H,100,116)(H,105,121)(H,106,122)(H,107,117)(H,108,119)(H,109,120)(H,110,123)(H,111,118)(H4,97,98,101)/t58-,62-,63-,70-,71-,75+,76+,77+,78+,79+,80-,81-,82-,83-,86+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
135n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144765
PNG
(US8952128, 24)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
175n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 55 total )  |  Next  |  Last  >>